leisure time -WSS

leisure time

author：explore 2025-09-07 17:23:47 - browse：87

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： 3 medical device trends to watch in 2024

WSS

CDC advisers recommend seasonal use of Pfizer RSV shot

Senate HELP committee spars over health care workforce policies

Microbiome research is starting to find links to chronic diseases

Feng Zhang, Grail founder join forces on new gene editing startup

Experts study whether long Covid risk adds up with each reinfection

Goldman Sachs launches $650M fund for life science investments

entertainment

leisure time

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

How AI helped researchers track recovery from depression

Supreme Court strikes down use of affirmative action

Biotech lab space demand falls sharply

In Memoriam: Notable people who died in 2023

Readout LOUD podcast: possible new ALS drug, artificial wombs

State Dept. review finds Biden bears some blame for Afghanistan failures

Federal weight loss drug coverage is 30 years out of date

State Dept. review finds Biden bears some blame for Afghanistan failures

CommonSpirit Health keeps growing, even as it loses money

leisure time

CommonSpirit Health keeps growing, even as it loses money

How a scoliosis diagnosis changed the life of one young dancer

The biotech scorecard for Q1: 17 stock

Ahead of JPM, here's who's profiting most in health care

How AI helped researchers track recovery from depression

Burning questions for the 2024 JPM Healthcare Conference

focus

focus

hotspot

knowledge